Inspira Technologies Outlines Strategic Vision, Planned Liquid Biopsy Expansion

Inspira Technologies, a pioneer in life-support and diagnostic technologies, outlines a strategic vision for its expansion into liquid biopsy diagnostics. The company plans to acquire an advanced liquid biopsy platform alongside a concurrent equity investment, positioning it for long-term growth while protecting shareholder value. The transaction framework is designed to preserve shareholder value and enable future dividend distributions.